Clinical Trial

Sulodexide in Controlling the Recurrence of Psoriasis

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 21, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, double-blinded，controlled clinical trial. The purpose of the study is to evaluate the efficacy and safety of Sulodexide versus placebo in preventing psoriasis recurrence in patients with plaque psoriasis who have discontinued biologic therapy after achieving clinical cure.
Trial Details
NCT Number NCT06982196
Lead Sponsor Xijing Hospital
Conditions Psoriasis (PsO), Randomised Controlled Trial
Enrollment 160 participants
Start Date 2025-04-20
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-21